Lymphadenopathy in COVID-19 Vaccine Recipients: Diagnostic Dilemma in Oncologic Patients

Radiology. 2021 Jul;300(1):E296-E300. doi: 10.1148/radiol.2021210275. Epub 2021 Feb 24.

Abstract

Five cases of axillary lymphadenopathy are presented, which occurred after COVID-19 vaccination and mimicked metastasis in a vulnerable oncologic patient group. Initial radiologic diagnosis raised concerns for metastasis. However, further investigation revealed that patients received COVID-19 vaccinations in the ipsilateral arm prior to imaging. In two cases, lymph node biopsy results confirmed vaccination-related reactive lymphadenopathy. Ipsilateral axillary swelling or lymphadenopathy was reported based on symptoms and physical examination in COVID-19 vaccine trials. Knowledge of the potential for COVID-19 vaccine-related ipsilateral adenopathy is necessary to avoid unnecessary biopsy and change in therapy. © RSNA, 2021.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Breast Neoplasms / pathology*
  • COVID-19 / prevention & control
  • COVID-19 Vaccines / adverse effects*
  • Diagnosis, Differential
  • Female
  • Humans
  • Liposarcoma, Myxoid / pathology*
  • Lymph Nodes / diagnostic imaging
  • Lymphadenopathy / diagnostic imaging*
  • Lymphadenopathy / etiology*
  • Lymphatic Metastasis / diagnosis*
  • Male
  • Melanoma / pathology*
  • Middle Aged
  • Positron Emission Tomography Computed Tomography / methods
  • SARS-CoV-2

Substances

  • COVID-19 Vaccines